Stock listing
OTC:EBOSY EBOS Group Limited Stock
US listing (OTC) of EBOS Group Limited · home listing NZX:EBO
Follow EBOS Group Limited into a list and get an email when it puts out news.
Share price · OTC:EBOSY
$22.68 USD 0.00 (0.0%)
Close on Nov 6, 2026
- Day range
- $22.68 – $22.68 USDNov 6, 2026
- 52-week range
- $19.66 – $46.64 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $1,516 USDMedian day 0 shares · 58 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:EBO | $17.93 AUD | +0.04 (+0.2%) | 99,710 | $17.89 | $18.01 | $17.64 | $17.89 | Close on Nov 20, 2026 |
| OTC:EBOSY | $22.68 USD | 0.00 (0.0%) | — | $22.68 | $22.68 | $22.68 | $22.68 | Close on Nov 6, 2026 |
| Frankfurt:EJG | €10.40 EUR | 0.00 (0.0%) | — | €10.40 | €10.40 | €10.40 | €10.40 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:EBOSY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | 0.00 | 0.0% | $22.68 | $22.68 | $22.68 | 0 | |
| $22.68 | +3.02 | +15.4% | $22.68 | $22.68 | $22.68 | 524 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 100 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | 0.00 | 0.0% | $19.66 | $19.66 | $19.66 | 0 | |
| $19.66 | -3.64 | -15.6% | $19.66 | $19.66 | $19.66 | 233 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | 0.00 | 0.0% | $23.30 | $23.30 | $23.30 | 0 | |
| $23.30 | +0.712 | +3.1% | $23.30 | $23.30 | $23.30 | 106 | |
| $22.59 | 0.00 | 0.0% | $22.59 | $22.59 | $22.59 | 0 | |
| $22.59 | -3.442 | -13.2% | $22.59 | $22.59 | $22.59 | 730 | |
| $26.03 | 0.00 | 0.0% | $26.03 | $26.03 | $26.03 | 0 | |
| $26.03 | +0.03 | +0.1% | $26.03 | $26.03 | $26.03 | 211 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | -0.10 | -0.4% | $26.61 | $26.61 | $26.00 | 1,455 | |
| $26.10 | 0.00 | 0.0% | $26.00 | $26.10 | $26.00 | 695 | |
| $26.10 | +0.10 | +0.4% | $26.10 | $26.10 | $26.10 | 104 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 | |
| $26.00 | 0.00 | 0.0% | $26.00 | $26.00 | $26.00 | 0 |
- Ticker
- OTC:EBOSY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Apr 30, 2026
EBOS Group Sees Capex Declining From FY27; Targets Mid-Single-Digit EBITDA Growth Over Medium-Term
Latest earnings call · Aug 18, 2026
EBOS Group (NZX:EBO) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Oct 21, 2026
Shareholder Meeting (October 2026)
Shareholder meeting · 43 slides
Latest news
EBOS Group Sees Capex Declining From FY27; Targets Mid-Single-Digit EBITDA Growth Over Medium-Term
Apr 30, 2026
Closed $26.42 (0.0%) on Apr 30, 2026
EBO: Portfolio shift to high-growth sectors and disciplined investment drive sustained EBITDA growth
Apr 29, 2026
Closed $26.42 (0.0%) on Apr 30, 2026
EBOS Group Issues Update To FY26 Earnings Outlook
Apr 21, 2026
Closed $26.42 (0.0%) on Apr 22, 2026
ASX 200 stocks hitting fresh 52-week highs and lows – Week 12
Mar 15, 2026
Closed $37.69 (0.0%) on Mar 16, 2026
EBOS Group Limited H1 Income Advances
Feb 25, 2026
Closed $35.03 (0.0%) on Feb 25, 2026
EBO: Revenue up 13% and EBITDA up 3.2%, with FY26 guidance reaffirmed and strong segment growth
Feb 24, 2026
Closed $35.03 (0.0%) on Feb 24, 2026
ASX Insider Trades: Directors bought and sold these 7 stocks last week
Nov 16, 2025
Closed $37.48 (0.0%) on Nov 17, 2025
ASX 200 stocks with the best performance: Return, momentum, risk-vs-reward – Week 46
Nov 13, 2025
Closed $37.48 (0.0%) on Nov 14, 2025
EBOS Group Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 6 in the last 12 months · 26 in all · newest Apr 30, 2026 · oldest 2023
- Calls
- 3 calls with a replay · 3 with a transcript · latest Aug 18, 2026
- Decks
- 56 decks · latest Oct 21, 2026
Where EBOS Group Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NZX:EBO · Home listing | NZX | New Zealand | NZD |
| ASX:EBO | ASX | Australia | AUD |
| gettex:EJG | gettex | Germany | EUR |
| LS Exchange:724635 | LS Exchange | Germany | EUR |
| OTC:EBOSY · This page | OTC | United States | USD |
| OTC:EBOSF | OTC | United States | USD |
| Lang & Schwarz:724635 | Lang & Schwarz | Germany | EUR |
| Frankfurt:EJG | Frankfurt | Germany | EUR |
| Munich:EJG | Munich | Germany | EUR |
| Dusseldorf:EJG | Dusseldorf | Germany | EUR |
| Stuttgart:EJG | Stuttgart | Germany | EUR |
Team and board
Officers
| Officer | Role |
|---|---|
| Adam Hall | CHIEF EXECUTIVE OFFICER |
| Brett Barons | CEO - SYMBION & HEALTHCARE DISTRIBUTION |
| Grant Viney | CEO - Animal Care |
| Kristine James | CEO - MEDICAL TECHNOLOGY |
| Nick Munroe | CEO - Retail Pharmacy Brands |
| Alistair Gray | CHIEF FINANCIAL OFFICER |
| Janelle Cain | GENERAL COUNSEL |
| Jacinta McCarthy | EXECUTIVE GENERAL MANAGER HUMAN RESOURCES |
| Matt Muscio | Non–Executive Director |
| Mithran Naiker | CHIEF INFORMATION OFFICER |
Board
| Director | Role |
|---|---|
| Elizabeth Coutts | INDEPENDENT CHAIR |
| Coline McConville | INDEPENDENT DIRECTOR |
| Julie Tay | Independent Director |
| Mark Bloom | INDEPENDENT DIRECTOR |
| Matt Muscio | Non–Executive Director |
| Stuart McLauchlan | INDEPENDENT DIRECTOR |
| Tracey Batten | INDEPENDENT DIRECTOR |
Events
| Call | When | Status |
|---|---|---|
| EBOS Group (NZX:EBO) Q4 2026 Earnings Call | Tue, Aug 18, 2026 · 7:00 PM ET | Replay |
| EBOS Group (NZX:EBO) Q2 2026 Earnings Call | Wed, Feb 25, 2026 · 7:30 PM ET | Replay |
| EBOS Group (NZX:EBO) Q4 2025 Earnings Call | Wed, Aug 27, 2025 · 7:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (October 2026) | Shareholder meeting | 43 slides | Oct 21, 2026 |
| FY2026 Earnings Presentation | Earnings | 31 slides | Aug 19, 2026 |
| Investor Day (April 2026) | Investor day | 62 slides | Apr 30, 2026 |
| Investor Day (April 2026) | Investor day | 63 slides | Apr 30, 2026 |
| H1 FY26 Earnings Presentation | Earnings | 35 slides | Feb 25, 2026 |
| Shareholder Meeting (October 2025) | Shareholder meeting | 50 slides | Oct 29, 2025 |
| FY2025 Earnings Presentation | Earnings | 32 slides | Aug 28, 2025 |
| Investor Presentation (April 2025) | Investor deck | 38 slides | Apr 10, 2025 |
| H1 FY25 Earnings Presentation | Earnings | 34 slides | Feb 19, 2025 |
| Shareholder Meeting (October 2024) | Shareholder meeting | 47 slides | Oct 23, 2024 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2024 Earnings Presentation | Earnings | 36 slides | Aug 21, 2024 |
| Macquarie Australia Conference 2024 | Conference | 31 slides | May 7, 2024 |
| H1 FY24 Earnings Presentation | Earnings | 33 slides | Feb 21, 2024 |
| Shareholder Meeting (October 2023) | Shareholder meeting | 55 slides | Oct 24, 2023 |
| FY2023 Earnings Presentation | Earnings | 37 slides | Aug 23, 2023 |
| Macquarie Australia Conference 2023 | Conference | 30 slides | May 3, 2023 |
| H1 FY23 Earnings Presentation | Earnings | 30 slides | Feb 22, 2023 |
| Investor Day (November 2022) | Investor day | 69 slides | Nov 16, 2022 |
| Shareholder Meeting (October 2022) | Shareholder meeting | 53 slides | Oct 27, 2022 |
| FY2022 Earnings Presentation | Earnings | 33 slides | Aug 24, 2022 |
| Macquarie Australia Conference 2022 | Conference | 32 slides | May 4, 2022 |
| H1 FY2022 Earnings Presentation | Earnings | 29 slides | Feb 16, 2022 |
| Merger or Acquisition (December 2021) | Merger or acquisition | 60 slides | Dec 9, 2021 |
| Shareholder Meeting (October 2021) | Shareholder meeting | 47 slides | Oct 19, 2021 |
| FY2021 Earnings Presentation | Earnings | 35 slides | Aug 18, 2021 |
| Macquarie Australia Conference 2021 | Conference | 27 slides | May 5, 2021 |
| H1 FY21 Earnings Presentation | Earnings | 33 slides | Feb 17, 2021 |
| Shareholder Meeting (October 2020) | Shareholder meeting | 45 slides | Oct 13, 2020 |
| FY2020 Earnings Presentation | Earnings | 31 slides | Aug 20, 2020 |
| Macquarie Australia Conference 2020 | Conference | 22 slides | May 5, 2020 |
| H1 FY20 Earnings Presentation | Earnings | 28 slides | Feb 20, 2020 |
| UBS Australasia Conference 2019 | Conference | 22 slides | Nov 18, 2019 |
| Shareholder Meeting (October 2019) | Shareholder meeting | 25 slides | Oct 15, 2019 |
| FY2019 Earnings Presentation | Earnings | 29 slides | Aug 22, 2019 |
| Investor Presentation (April 2019) | Investor deck | 24 slides | Apr 30, 2019 |
| H1 FY19 Earnings Presentation | Earnings | 27 slides | Feb 20, 2019 |
| Corporate Update (January 2019) | Corporate update | 11 slides | Jan 25, 2019 |
| Investor Day (November 2018) | Investor day | 41 slides | Nov 14, 2018 |
| Shareholder Meeting (October 2018) | Shareholder meeting | 22 slides | Oct 16, 2018 |
| FY2018 Earnings Presentation | Earnings | 32 slides | Aug 23, 2018 |
| H1 FY2018 Earnings Presentation | Earnings | 29 slides | Feb 21, 2018 |
| Shareholder Meeting (October 2017) | Shareholder meeting | 21 slides | Oct 17, 2017 |
| FY2017 Earnings Presentation | Earnings | 33 slides | Aug 24, 2017 |
| H1 FY2017 Earnings Presentation | Earnings | 27 slides | Feb 22, 2017 |
| UBS Australasia Conference 2016 | Conference | 14 slides | Nov 7, 2016 |
| Shareholder Meeting (October 2016) | Shareholder meeting | 21 slides | Oct 19, 2016 |
| FY2016 Earnings Presentation | Earnings | 30 slides | Aug 25, 2016 |
| H1 FY16 Earnings Presentation | Earnings | 29 slides | Feb 24, 2016 |
| UBS Australasia Conference 2015 | Conference | 15 slides | Nov 17, 2015 |
| Shareholder Meeting (October 2015) | Shareholder meeting | 22 slides | Oct 27, 2015 |
This page holds 50 of 56 decks. Open Decks
Filings
Cap table
Built by 6ix from EBOS Group Limited’s releases
- Common shares
- 209,062,887
- Fully diluted
- 209,062,887
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 209,062,887 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 209,062,887 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adam Hall | CHIEF EXECUTIVE OFFICER · Since at least Nov 5, 2026 |
| Alistair Gray | CHIEF FINANCIAL OFFICER · Since at least Nov 5, 2026 |
| Brett Barons | CEO - SYMBION & HEALTHCARE DISTRIBUTION · Since at least Nov 5, 2026 |
| Coline McConville | INDEPENDENT DIRECTOR · Since at least Nov 5, 2026 |
| Elizabeth Coutts | INDEPENDENT CHAIR · Since at least Sep 29, 2025 |
| Grant Viney | CEO - Animal Care · Since at least Nov 5, 2026 |
| Jacinta McCarthy | EXECUTIVE GENERAL MANAGER HUMAN RESOURCES · Since at least Nov 5, 2026 |
| Janelle Cain | GENERAL COUNSEL · Since at least Nov 5, 2026 |
| Julie Tay | Independent Director · Since at least Oct 14, 2025 |
| Kristine James | CEO - MEDICAL TECHNOLOGY · Since at least Nov 5, 2026 |
All 16 people
| Person | Seat |
|---|---|
| Mark Bloom | INDEPENDENT DIRECTOR · Since at least Jun 10, 2025 |
| Matt Muscio | Non–Executive Director · Since at least Nov 5, 2026 |
| Mithran Naiker | CHIEF INFORMATION OFFICER · Since at least Nov 5, 2026 |
| Nick Munroe | CEO - Retail Pharmacy Brands · Since at least Nov 5, 2026 |
| Stuart McLauchlan | INDEPENDENT DIRECTOR · Since at least Sep 29, 2025 |
| Tracey Batten | INDEPENDENT DIRECTOR · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about EBOS Group Limited.